At the International Kidney Stone Institute, our goal is nothing less than the cure.

Research References

1. Lingeman JE.  Pathogenesis of nephrolithiasis.  J Urol 189:417-418, February 2013
2. Handa RK, McAteer JA, Connors BA, Liu Z, Lingeman JE, Evan AP.  Optimizing an escalating shock wave amplitude treatment strategy to protect the kidney from injury during shock wave lithotripsy.  BJUI 110:1041-1047, December 2012
3. Pishchalnikov YA, McAteer JA, Williams JC Jr, Connors BA, Handa R, Lingeman JE, Evan AP.  Evaluation of the LithoGold LG-380 lithotriptor:  in vitro acoustic characterization and assessment of renal injury in the pig model.  J Endourol, on line, December 2012
4. Connors BA, McAteer JA, Evan AP, Blomgren PM, Handa RK, Johnson CD, Gao S, Pishchalnikov YI, Lingeman JE.  Evaluation of shock wave lithotripsy injury in the pig using a narrow focal zone lithotriptor.  BJUI 110:1376-1385, November 2012
5. Williams JC, Hameed T, Jackson ME, Aftab S, Gambaro A, Pishchalnikov YA, Lingeman JE, McAteer JA.  Fragility of brushite stones in shock wave lithotripsy:  absence of correlation with CT-visible structure.  J Urol, 188:996-1001, September 2012
6. Childs MA, Rangel LJ, Lingeman JE, Krambeck AE.  Factors influencing urologist treatment preferences in surgical management of stone disease.  Urology 79(5):996-1003, May 2012
7. Connors BA, McAteer JA, Evan AP, Blomgren PM, Handa RK, Johnson CD, Gao S, Pishchalnikov YA, Lingeman JE.  Evaluation of shock wave lithotripsy injury in the pig using a narrow focal zone lihtotriptor.  BJUI, April 2012
8. Gnessin E, Mandeville JA, Handa SE, Lingeman JE.  The utility of noncontrast computed tomography in the prompt diagnosis of postoperative complications after percutaneous nephrolithotomy.  J Endo 26(4):347-350, April 2012
9. Williams JC, Sacks AJ, Englert K, Deal R, Farmer TL, Jackson ME, Lingeman JE, McAteer JA.  Stability of the infection marker struvite in urinary stone samples.  J Endo 25, October 2011, online publication
10. Gnessin E, Mandeville JA, Handa SE, Lingeman JE.  Changing composition of renal calculi in patients with musculoskeletal anomalies.  J Endo 25(9):1519-1523, September 2011
11. Williams JC Jr., McAteer JA, Evan AP, Lingeman JE.  Micro-computed tomography for analysis of urinary calculi.  Urol Res 38:477-484, December 2010
12. Miller NL, Humphreys MR, Coe FL, Evan AP, Bledsoe SB, Handa SE, Lingeman JE.  Nephrocalciinosis:  re-defined in the era of endourology.  Urol Res 38:421-427, December 2010
13. Krambeck AE, Khan NF, Jackson ME, Lingeman JE, McAteer JA, Williams JC Jr.  Inaccurate reporting of mineral composition by commercial stone analysis laboratories:  implications for infection and metabolic stones.  J Urol 184:1543-1549, October 2010
14. Krambeck AE, Handa SE, Evan AP, Lingeman JE.  Profile of the brushite stone former.  J Urol 184:1367-1371, October 2010
15. Evan AP, Lingeman JE, Worcester EM, Bledsoe SB, Sommer AJ, Williams JC Jr., Krambeck AE, Philips CL, Coe, FL.  Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease.  Kidney Intl 78:310-317, August 2010
16. Coe FL, Evan AP, Lingeman JE, Worcester EM.  Plaque and deposits in nine human stone diseases.  Urol Res 38(4):239-247, August 2010
17. Coe FL, Evan AP, Worcester EM, Lingeman JE.  Three pathways for human kidney stone formation.  Urol Res 38:147-160, June 2010
18. Miller NL, Williams, Jr. JC, Evan AP, Bledsoe SB, Coe FL, Worcester EM, Munch LC, Handa SE, Lingeman JE. In idiopathic calcium oxalate stone formers, unattached stones show evidence of having originated as attached stones on Randall's plaque. BJU Intl 105:242-245, January 2010
19.  Lingeman JE, McAteer JA, Gnessin E, Evan AP. Shock wave lithotripsy: advances in technology and technique. Nature Reivews Urology 6:660-670, December 2009
20. Handa RK, Evan AP, Willis LR, Johnson CD, Connors BA, Gao S, Lingeman JE, Matlaga BR, Miller NL, Handa SE. Renal functional effects of multiple tract percutaneous access. J Endo 23:1951-1956, December 2009
21. Krambeck AE and Lingeman JE. Percutaneous management of calyceal diverticuli. J Endo 23:1723-1729, October 2009
22. Connors BA, Evan AP, Blomgren PM, Handa RK, Willis LR, Gao S, McAteer JA, Lingeman JE. Extracorporeal shock wave lithotripsy at 60 shock waves/min reduces renal injury in a porcine model. BJU Intl 104:1004-1008, September 2009
23. Evan AP, Lingeman JE, Coe FL, Bledsoe SB, Sommer AJ, Williams Jr. JC, Krambeck AE, Worcester EM. Intra-tubular deposits, urine and stone composition are divergent in patients with ileostomy. Kidney Intl 76:1081-1088, August 2009
24. Parks JH, Coe FL, Evan AP, Worcester EM. Clinical and laboratory characteristics of calcium stone formers with and without primary hyperparathyroidism. BJU Intl 103:670-678, 2009
25. Park JH, Coe FL, Evan AP, Worcester EM. Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrology Dialysis Transplantation 24:130-136, 2009
26. Miller NL, Gillen DL, WIlliams, Jr. JC, Evan AP, Bledsoe SB, Coe FL, Worcester EM, Matlaga BR, Munch LC, Lingeman JE. A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall's plaque. BJU Intl 103:966-971, April 2009
27. McAteer JA, Evan AP, Williams, Jr. JC, Lingeman JE. Treatment protocols to reduce renal injury during shock wave lithotripsy. Curr Opin Urol 19(2):192-195, March 2009
28. Matlaga BR, Lingeman JE. Surgical management of stones: new technology. Adv Chronic Kidney Dis 16(1):60-64, January 2009
29. Patel BN, Passman CM, Fernandez A, Asplin JR, Coe FL, Kim SC, Lingeman JE, Assimos DG. Prevalence of hyperoxaluria after bariatric surgery. J Urol 181:161-166, January 2009
30. Evan AP, Lingeman JE, Coe FL, Miller NL, Bledsoe SB, Sommer AJ, Williams, Jr. JC, Shao Y, Worcester EM. Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones. Kidney Intl 74(2):223-229, July 2008
31. Miller NL, Matlaga BR, Handa SE, Munch LC, Lingeman JE. The presence of horseshoe kidney does not affect the outcome of percutaneous nephrolithotomy. J Endourol 22(6):1219-1225, June 2008
32. Ross AE, Handa S, Lingeman JE, Matlaga BR. Kidney stones during pregnancy: an investigation into stone composition. Urol Res 36:99-102, May 2008
33. Evan AP, Coe FL, Gillen D, Lingeman JE, Bledsoe S, Worcester EM. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. The Anatomical Record 291:325-334, March 2008
34. Evan AP, Lingeman JE, Coe FL, Worcester EM. Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone. Seminars of Nephrology 28(2):111-119, March 2008
35. Humphreys MR, Miller NL, Williams, Jr. JC, Evan AP, Munch LC, Lingeman JE. A new world revealed: early experience with digital ureteroscopy. J Urol 179:970-975, March 2008
36. Evan AP, McAteer JA, Connors BA, Pishchalnikov YA, Handa RK, Blomgren P, Willis LR, Williams, Jr. JC, Lingeman JE, Gao S. Independent assessment of a wide-focus, low-pressure electromagnetic lithotriptor: absence of renal bioeffects in the pig. BJU Intl 101:382-388, February 2008
37. Matlaga BR, McAteer JA, Connors BA, Handa RK, Evan AP, Williams, Jr. JC, Lingeman JE, Willis LR. Potential for cavitation-mediated tissue damage in shock wave lithotripsy. J Endourol 22(1):121-126, January 2008
38. Evan AP, Coe FL, Lingeman JE, Shao Y, Sommer AJ, Bledsoe SB, Anderson JC, Worcester EM. Mechanism of formation of human calcium oxalate renal stones on Randall's plaque. The Anatomical Record 290:1315-1323, October 2007
39. Evan AP, McAteer JA, Connors BA, Blomgren PM, Lingeman JE. Renal injury during shock wave lithotripsy is significantly reduced by slowing the rate of shock wave delivery. BJU Intl 100:624-628, September 2007
40. Miller NL, Evan AP, Lingeman JE. Pathogenesis of renal calculi. Urol Clin North Am 34:295-313, August 2007
41. Miller NL, Lingeman JE. Management of kidney stones. BMJ 334:468-472, March 2007
42. Matlaga BR, Miller NL, Terry C, Kim SC, Kuo RL, Coe FL, Evan AP, Lingeman JE. The pathogenesis of calcyceal diverticular calculi. Urol Res 35:35-40, February 2007
43. Matlaga BR, Coe FL, Evan AP, Lingeman JE. The role of Randall's plaque in the pathogenesis of calcium stones. J Urol 177:31-38, January 2007
44. Evan AP, Lingeman JE, Coe FL, Shao Y, Miller NL, Matlaga BR, Phillips C, Sommer A. Worcester E. Renal histopathology of stone-forming patients with distal renal tubular acidosis. Kidney Intl 71:795-801, January 2007
45. Evan AP, Coe FL, Lingeman JE, Shao Y, Matlaga BR, Kim SC, Bledsoe SB, Sommer AJ, Grynpas M, Phillips CL, Worcester EM. Renal crystal deposits and histopathology in patients with cystine stones. Kidney Intl 69:2227-2235, June 2006
46. Miller NL, Lingeman JE. Treatment of kidney stones: current lithotripsy devices are proving less effective in some cases. Nature Clinical Practice Urology 3(5):236-237, May 2006
47. Matlaga BR, Williams, Jr. JC, Kim SC, Kuo RL, Evan AP, Bledsoe SB, Coe FL, Worcester EM, Munch LC, Lingeman JE. Endoscopic evidence of calculus attachment to Randall's plaque. J Urol 175(5):1720-1724, May 2006
48. Evan AP, Lingeman JE, Coe FL, Worcester EM. Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Intl 69(8):1313-1318, April 2006
49. Willis LR, Evan AP, Connors BA, Handa RK, Blomgren PM, Lingeman JE. Prevention of lithotripsy-induced renal injury by pre-treating kidneys with low-energy shock waves. J Am Soc Nephrol 17(3):663-673, March 2006